L-Pipecolic acid - ≥98% , CAS No.3105-95-1

CAS: 3105-95-1 Cat. No.: P106214 Fórmula: C6H11NO2 Peso molecular: 129.16 Beilstein Registry Number: 81093 Número CE: 221-462-1
Disponível para encomenda
GRAU & PUREZA ≥98%
Synonyms
(-)-Pipecolate|L-Homoproline|L-(-)-Pipecolate|L-pipecolate|(S)-Piperidine-2-carboxylicacid|(l)-pipecolic acid|L-(-)-Pipecolinic acid|l(-)-pipecolinic acid|L-Pipecolinate|YCP|(l)-pipecolinic acid|(S)-pipecolate|8-fluoro-4-oxo-1,4-dihydro-3-quinolinecarboxylicacid|l-Pipecolic acid|l-piperidine-2-carboxylic acid|(-)-PIPECOLINIC ACID|Piperidine-2-carboxylic acid;H-HoPro-OH|(S)-Piperidine-2-carboxylic acid|Pipecolic acid, L-(-)-|(S)-pipecolic acid|(S)-piperidine-2-carboxylate|2(S)-Piperidinecarboxylic acid|L-Piperidine-2-carboxylate|(S)-(-)-2-Piperidinecarboxylic acid|(S)(-)-2-piperidinecarboxylic acid|(S)-Pipecolinate|(S)-(-)-pipecolic acid|h-homopro-oh|Pipecolic acid, (-)-|(-)-Pipecolic acid|(2S)-piperidine-2-carboxylic acid|(S)-2-Piperidinecarboxylate|(S)-Piperidine-2-carboxylic acid;|(S)-(-)-2-Piperidinecarboxylate|(S)-2-Piperidinecarboxylic acid|(S)-(-)-Pipecolate|L-(-)-pipecolic acid|L-Pipecolinic acid|S)-2-Piperidinecarboxylic acid|(S)-Pipecolinic acid|2-Piperidinecarboxylic acid, (2S)-|PIPECOLIC ACID L-FORM [MI]
Storage
Room temperature
Shipped In
Normal
★
Tamanho
USA
Alemanha (EU)*
Preço
Qtd
1g
P106214-1g
2 Em stock
—

9,90US$

14,90US$
Gravar 5,00 US$ (33.56%)
5g
P106214-5g
4 Em stock
—

11,90US$

17,90US$
Gravar 6,00 US$ (33.52%)
25g
P106214-25g
3 Em stock
—

28,90US$

43,90US$
Gravar 15,00 US$ (34.17%)
100g
P106214-100g
1 Em stock
1 Em stock

91,90US$

137,90US$
Gravar 46,00 US$ (33.36%)
Enter a quantity for the sizes you want to add.

Visão geral

application:

L-Pipecolinic acid is involved in synaptic transmission in the central nervous system. It is also used as pharmaceutical intermediate.

Especificações

Sinónimos
(-)-Pipecolate | L-Homoproline | L-(-)-Pipecolate | L-pipecolate | (S)-Piperidine-2-carboxylicacid | (l)-pipecolic acid | L-(-)-Pipecolinic acid | l(-)-pipecolinic acid | L-Pipecolinate | YCP | (l)-pipecolinic acid | (S)-pipecolate | 8-fluoro-4-oxo-1,4-dihydro-3-quinolinecarboxylicacid | l-Pipecolic acid | l-piperidine-2-carboxylic acid | Show more
Especificações e pureza
≥98%
Mecanismos bioquímicos e fisiológicos
H-HoPro-OH is a breakdown product of lysine, accumulates in body fluids of infants with generalized genetic peroxisomal disorders, such as Zellweger syndrome, neonatal adrenoleukodystrophy.
Condições de armazenamento de armazenamento
Room temperature
Enviado em
Normal
Pureza
≥98%
Nomes e identificadores
Pubchem Sid
Pubchem Sid Url
https://pubchem.ncbi.nlm.nih.gov/substance/488189737
SMILES
C1CCNC(C1)C(=O)O
IUPAC Name
(2S)-piperidine-2-carboxylic acid
InChIKey
HXEACLLIILLPRG-YFKPBYRVSA-N
InChI
1S/C6H11NO2/c8-6(9)5-3-1-2-4-7-5/h5,7H,1-4H2,(H,8,9)/t5-/m0/s1
SMILES isoméricas
C1CCN[C@@H](C1)C(=O)O
WGK Alemanha
3
Peso molecular
129.16
Beilstein
81093
Reaxys
81095
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=81095&ln=

Dados avançados

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassOrganic acids and derivatives
ClasseCarboxylic acids and derivatives
SubclassAmino acids, peptides, and analogues
Intermediate Tree Nodes Amino acids and derivatives - Alpha amino acids and derivatives - Alpha amino acids
Direct ParentL-alpha-amino acids
Alternative Parents Piperidinecarboxylic acids  Amino acids  Monocarboxylic acids and derivatives  Dialkylamines  Carboxylic acids  Azacyclic compounds  Organopnictogen compounds  Organic oxides  Hydrocarbon derivatives  Carbonyl compounds  
Molecular FrameworkAliphatic heteromonocyclic compounds
Substituents L-alpha-amino acid - Piperidinecarboxylic acid - Piperidine - Amino acid - Carboxylic acid - Secondary aliphatic amine - Monocarboxylic acid or derivatives - Secondary amine - Organoheterocyclic compound - Azacycle - Organic oxygen compound - Organic nitrogen compound - Organooxygen compound - Organonitrogen compound - Amine - Carbonyl group - Organopnictogen compound - Hydrocarbon derivative - Organic oxide - Aliphatic heteromonocyclic compound
DescriçãoThis compound belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom.
External Descriptors Piperidine alkaloids
Estrutura 3D
Modelo de Estrutura Química Interativa





Alvos associados (humanos)
PIPOX Tbio Peroxisomal sarcosine oxidase (13 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mecanismos de ação
Certificados(CoA,COO,BSE/TSE e Mapa de Análise)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

15 results found

Lot NumberCertificate TypeDataItem
K2108080K2108080Certificate of AnalysisAug 12, 2025 P106214
K2108194K2108194Certificate of AnalysisAug 12, 2025 P106214
L2424457L2424457Certificate of AnalysisJun 18, 2024 P106214
L2424458L2424458Certificate of AnalysisJun 18, 2024 P106214
H2302903H2302903Certificate of AnalysisJul 11, 2023 P106214
H2302907H2302907Certificate of AnalysisJul 11, 2023 P106214
H2302911H2302911Certificate of AnalysisJul 11, 2023 P106214
H2302913H2302913Certificate of AnalysisJul 11, 2023 P106214
H2302914H2302914Certificate of AnalysisJul 11, 2023 P106214
H2302917H2302917Certificate of AnalysisJul 11, 2023 P106214
H2302919H2302919Certificate of AnalysisJul 11, 2023 P106214
H2302923H2302923Certificate of AnalysisJul 11, 2023 P106214
D1918091D1918091Certificate of AnalysisFeb 03, 2023 P106214
G1802128G1802128Certificate of AnalysisMay 06, 2022 P106214
D2307361D2307361Certificate of AnalysisSep 25, 2021 P106214
Propriedades químicas e físicas
Solubilidadeinsoluble in EtOH; insoluble in DMSO; ≥23 mg/mL in H2O
Rotação específica [α]-27 ° (C=4, H2O)
Ponto de fusão (°C)272°C
Peso molecular129.16
XLogP3-2.300
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count3
Rotatable Bond Count1
Exact Mass129.079 Da
Monoisotopic Mass129.079 Da
Topological Polar Surface Area49.300 Ų
Heavy Atom Count9
Formal Charge0
Complexity114.000
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Segurança e perigos (GHS)
Pictograma(s)
Sinal
Warning
Declarações de perigo

H315:Causes skin irritation

H319:Causes serious eye irritation

H335:May cause respiratory irritation

Declarações de precaução

P261:Avoid breathing dust/fume/gas/mist/vapors/spray.

P264:Wash hands [and …] thoroughly after handling.

P271:Use only outdoors or in a well-ventilated area.

P280:Wear protective gloves/protective clothing/eye protection/face protection.

P321:Specific treatment (see ... on this label).

P302+P352:IF ON SKIN: wash with plenty of water.

P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing.

P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing.

P362+P364:Take off contaminated clothing and wash it before reuse.

P405:Store locked up.

P403+P233:Store in a well-ventilated place. Keep container tightly closed.

P501:Dispose of contents/container to an approved waste disposal plant.

P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes.

P337+P317:If eye irritation persists: Get medical help.

P332+P317:If skin irritation occurs: Get medical help.

P319:Get medical help if you feel unwell.

WGK Alemanha
3
Reaxys
81095
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=81095&ln=
Índice Merck
7458
FAQs e artigos
Citations of This Product
Calculadoras de soluções
Revisões

Avaliações dos Clientes

Application Protocols

No vendor-validated bioassay protocols are specified for this item. Typical laboratory uses include:

  • Preparation of stock solutions:

    • Dissolve in water or buffer to 0.1–1.0 M; adjust pH with HCl or NaOH to ensure full dissolution away from the isoelectric point. Filter sterilize through 0.22 µm if sterility is required.
  • General coupling (solution-phase) procedure (example framework; adjust per project):

    • Dissolve L-pipecolic acid (1.0 eq) and the amine partner (1.1 eq) in anhydrous DMF.
    • Add Oxyma (1.1 eq) and DIPEA (2–3 eq), cool to 0–5 °C.
    • Add HATU (1.1 eq) portion-wise, stir 1–4 h at 0–25 °C.
    • Quench with water, extract (if protected, use EtOAc), or precipitate into cold ether; purify by chromatography or crystallization.
  • N-Boc protection (framework):

    • Suspend L-pipecolic acid in aqueous NaHCO3, cool, add (Boc)2O (1.2 eq) in dioxane, stir 0–25 °C to completion; isolate by concentration and crystallization.

These are general templates derived from literature practice and should be optimized and validated in your laboratory. For application-specific SOPs, consult primary references.

Biological Roles
  • General context (biochemistry; not medical/clinical):

    • L-Pipecolic acid is a cyclic analog of L-proline and participates in lysine catabolism pathways in many organisms. In plants and microbes, pipecolate and its oxidized derivatives are intermediates in metabolic and signaling processes related to stress responses (literature).
    • In animals, L-pipecolate arises from L-lysine via saccharopine-independent pathways; it can be further metabolized by peroxisomal oxidases to Δ1-piperideine-6-carboxylate, feeding into downstream metabolism (literature).
  • Physicochemical/biological features:

    • Zwitterionic nature near neutral pH influences transport across membranes; dedicated amino acid transporters or active transport mechanisms are commonly required (organism-dependent; literature).
    • The piperidine nitrogen is more basic than in proline, which can alter enzyme binding and reactivity compared with open-chain analogs.
  • Utility in biological experiments (research use only):

    • Employed as a standard, substrate, or reference in studies of lysine degradation and peroxisomal metabolism.
    • Used to probe structure–activity relationships in proline-dependent enzymes or peptidomimetics where ring size modulates binding.
    • Incorporated into peptides to modulate secondary structure and proteolytic stability; cyclic residue can bias cis/trans amide preferences relative to proline.

Note: Any biological use must be confined to non-clinical research. Verify cell/tissue compatibility and adjust pH/osmolality when preparing solutions.

Buffer Applications

Not a standard buffering reagent. As a zwitterionic amino acid analog, L-pipecolic acid exhibits acid/base behavior (pKa ~2.3 for –COOH; pKa ~10.8 for –NH2+; literature), but it is not used as a canonical Good’s buffer or analytical buffer.

  • If used for exploratory buffering (research only):

    • Effective buffering regions would lie roughly within ±1 pH unit of the pKa values (very acidic or strongly basic), which is rarely desirable for routine biochemical assays.
    • For physiological pH buffering, choose established systems (e.g., phosphate, HEPES, MOPS). L-pipecolic acid may be added as a component or cosolute to study specific biochemical effects rather than to control pH.
  • Practical preparation (if used as a solute):

    • Dissolve in water to the desired molarity; adjust pH with HCl or NaOH. Filter-sterilize if needed. Monitor ionic strength if high concentrations are used, as the zwitterion can influence conductivity.

Conclusion: Consider this compound as a substrate/solute rather than a buffer. Use dedicated buffering agents for precise pH control.

Green Alternatives
  • Context: L-Pipecolic acid is a solid building block rather than a process solvent. “Green alternatives” considerations therefore focus on sourcing, protecting-group strategy, and solvent choices in transformations using this substrate.

  • Sourcing (literature/general):

    • Biobased routes: L-Pipecolic acid can be prepared enzymatically or via biotransformation from L-lysine (chiral pool), reducing reliance on petrochemical chiral resolution.
    • Salt/solvate minimization: Selecting the free acid vs salt can reduce neutralization steps and salt waste, depending on the synthesis plan.
  • Solvent and reagent choices:

    • Prefer water or water-miscible green solvents (e.g., ethanol, 2-MeTHF, CPME) for workups and couplings when compatible.
    • For amide couplings, use greener coupling systems (e.g., DMTMM in water or EtOH) instead of DMF/HATU where feasible; consider ethyl chloroformate-free activation to reduce hazards.
  • Comparison of solvent options (general guidance):

    • DMF/NMP: high performance but reproductive-tox classification; consider minimizing or substituting with DMC, PC, or EtOAc + additives when workable.
    • DCM: effective for Boc-protection but volatile organic pollutant; replace with EtOAc or Me-THF when possible.
  • Waste minimization:

    • Use solid-supported scavengers for excess coupling reagents.
    • Apply aqueous crystallization of protected pipecolic derivatives to avoid chlorinated solvent extractions.

Note: Optimize alternatives case-by-case to meet performance and EHS targets without compromising stereochemical fidelity.

Pharmaceutical Uses

No therapeutic claims are made. This product is for research use only.

  • Formulation/excipient role: L-Pipecolic acid is not a common pharmaceutical excipient.

  • Process chemistry and intermediate roles (literature/general):

    • Chiral building block for synthesis of piperidine-containing active ingredient intermediates and peptidomimetics.
    • Incorporated into constrained peptides and small molecules to enhance metabolic stability or modulate receptor interactions during lead optimization.
    • Precursor to N-protected pipecolates (e.g., Boc-, Cbz-, Fmoc-protected) used in solid-phase and solution-phase amide couplings.
  • Regulatory considerations:

    • If used in GMP settings, control attributes typically include identity (NMR, IR), assay, optical rotation/chiral purity, residual solvents (ICH Q3C), elemental impurities (ICH Q3D), water content (Karl Fischer), and bioburden/endotoxin when relevant to process streams. For this catalog item, such specifications are not provided here; consult CoA/Spec Sheet or qualify in-house.
  • Handling in process development:

    • Salt selection (free acid vs HCl salt) may be used to tune solubility and crystallinity for isolation of intermediates.
    • Protecting group strategy is pivotal for chemoselectivity and minimizing racemization during scale-up.
Physical Properties
  • Item-specific specifications: Not specified for this item; refer to CoA/Spec Sheet.

  • Literature/typical values for L-pipecolic acid (for reference only; not product specifications):

    • Appearance: white to off-white crystalline solid (literature)
    • Melting point: commonly reported ~260–270 °C, often with decomposition (literature; values vary by source and enantiopurity)
    • Density: not widely tabulated; solid density not routinely used (literature)
    • Solubility: high in water; soluble in dilute mineral acids and bases; low solubility in most nonpolar organic solvents; limited in alcohols unless ionized (literature)
    • pKa (carboxyl): ~2.2–2.4 (literature)
    • pKa (aminium, ring N): ~10.6–11.2 (literature)
    • Isoelectric point (pI): ~6.3–6.7 (estimated from pKa; literature)
    • LogP (neutral form): negative/very low; logD is strongly pH-dependent (literature)
    • Optical rotation: sign and magnitude depend on solvent/concentration; reported [α]D values vary in water/acidic media (literature)
  • Practical notes (general chemistry knowledge):

    • As a zwitterionic α-amino acid analog, solubility increases at pH below ~2.5 (fully protonated) or above ~11 (deprotonated carboxylate with protonated amine). Near pI, aqueous solubility can decrease relative to acidic/basic media.
    • Hygroscopicity is typically low-to-moderate for cyclic amino acids, but minimize exposure to humid air to maintain mass accuracy for weighing (good laboratory practice).
Quality and Grades
  • Item-specific grade/purity: Not specified for this item; refer to CoA/Spec Sheet for assay, enantiomeric excess, residual solvents, and trace metals if controlled.

  • What “grade” typically implies (general guidance):

    • Research/biochemical grade: suitable for most synthetic and biochemical experiments; typical characterization includes NMR, HPLC, and optical rotation. Low levels of inorganic salts and residual solvents are expected.
    • Chiral quality: For L-pipecolic acid, the enantiomeric purity (ee or enantiomeric ratio) is often a critical attribute. Vendors may certify optical rotation and/or chiral HPLC—verify on the CoA.
    • Chromatography suitability: If intended for chiral pool synthesis or peptide coupling, low UV impurities and low water content are beneficial; when required, choose material labeled for peptide synthesis or >98–99% assay. If not specified, perform in-house qualification.
  • Stabilizers/additives: None are typically required for solid amino acids. If any stabilizer or salt form (e.g., hydrochloride) is supplied, it will be declared on the label/CoA; none are specified for this item.

  • Batch-to-batch consistency: For stereodefined building blocks like L-pipecolic acid, confirm identity by 1H/13C NMR, HRMS, IR (COOH ~1700 cm−1), and specific rotation. Chiral HPLC or derivatization (Marfey’s or Mosher-type) may be used to verify configuration if critical.

Reaction and Applications
  • Chiral pool building block (general/literature): L-Pipecolic acid is a versatile chiral source for constructing piperidine-containing scaffolds and for transferring (S) stereochemistry at C2 through amide formation, reductions, and ring transformations.

  • Representative applications:

    • Amide/peptide coupling: Formation of N-acyl pipecolamides using HATU/HBTU/EDC with bases (DIPEA, NMM) in DMF or NMP; protecting groups (Boc, Cbz, Fmoc) commonly used on the ring nitrogen to control chemoselectivity.
    • Lactam/lactamization strategies: Intramolecular cyclizations from pipecolic derivatives to access bicyclic alkaloid frameworks.
    • Reductive transformations: Conversion of the carboxylic acid to alcohol (via BH3·THF or LiAlH4 after activation) or to aldehyde (via mixed anhydride and mild reductants), enabling further elaboration.
    • Decarboxylative couplings: Activation (e.g., via N-hydroxyphthalimide esters) can enable radical-mediated C–C bond formations under photoredox or Ni catalysis (literature trend for amino acid derivatives).
    • Organocatalysis analogue: Although L-proline is canonical, L-pipecolic acid and its derivatives function in enamine/iminium catalysis, offering altered enantioselectivity and rate profiles due to ring size and basicity differences (literature).
  • Practical tips:

    • Protecting group strategy: Boc-protection on the ring N (Boc2O, base) enhances solubility in organic media and directs acylation to the carboxyl.
    • Salt forms: Temporary conversion to hydrochloride can improve handling and define stoichiometry for N-alkylation steps.
    • Stereointegrity: Avoid racemization during couplings by using uronium/oxyma systems and maintaining low basicity/temperature where possible.
Reaction Conditions

General conditions below are literature guidance for L-pipecolic acid and related amino acids; they are not specifications for this item.

  • Amide/peptide coupling:

    • Solvent: DMF or NMP (anhydrous); greener alternatives include EtOAc or mixed aqueous media with DMTMM.
    • Reagents: HATU (1.1–1.5 eq) or EDC·HCl (1.2–1.5 eq) + Oxyma/HOBt; base DIPEA (2–3 eq).
    • Temperature/time: 0–25 °C, 1–16 h. Minimize base and time to limit racemization.
    • Typical outcomes: high conversions to amides with minimal epimerization when oxyma-type additives are used (literature).
  • Boc protection of ring N:

    • Solvent: DCM, THF, or acetonitrile; water/MeOH possible with phase transfer.
    • Reagents: (Boc)2O (1.1–1.5 eq), base Na2CO3 or NaHCO3 (aq) or DIPEA (org.).
    • Conditions: 0–25 °C, 2–6 h; monitor by TLC/HPLC.
  • Esterification (Steglich):

    • Solvent: DCM/DMF; Reagents: DCC (1.1 eq) + DMAP catalytic; alcohol 2–5 eq.
    • Temperature: 0–25 °C; Time: 2–18 h. Filter dicyclohexylurea.
  • Decarboxylative cross-coupling via NHPI ester:

    • Formation: DIC (1.2 eq) + NHPI (1.2 eq) + DMAP in DCM/DMF (0–25 °C).
    • Coupling: Photoredox (Ir(ppy)3, blue LEDs) + Ni catalyst with alkyl/aryl halides in MeCN/DMF, rt–40 °C, 6–24 h (literature examples).
  • Reduction to alcohol/amine derivatives:

    • Convert to acid chloride (SOCl2) or mixed anhydride, then reduce with NaBH4 (for aldehyde) or LiAlH4/BH3·THF (to alcohol) at 0–25 °C (caution: gas evolution).

Always dry solvents/reagents as needed and verify stereochemistry post-reaction.

Safety and Handling
  • Item-specific hazard data (from Product Data): Not specified; GHS classification, signal word, H-statements, and pictograms are not provided for this item. Always consult the SDS for authoritative safety information.

  • General safety guidance (general chemistry knowledge):

    • Expected hazard profile: Many amino acids are of low acute toxicity and often nonhazardous under GHS; however, classification can vary by supplier and impurity profile. Defer to the SDS supplied with the lot.
    • Personal protective equipment (PPE): laboratory coat, safety glasses, and appropriate gloves (e.g., nitrile). Use dust control (avoid aerosol formation) and handle on a clean bench or in a fume hood if dusting.
    • Incompatibilities: strong oxidizers may degrade amines; strong acids/bases can alter form but are commonly used for dissolution. Avoid mixing with nitrosating agents (general amine precaution).
    • First aid measures (overview; consult SDS):
      • Inhalation: move to fresh air; seek medical attention if symptoms persist.
      • Skin/eye contact: rinse with water for several minutes; remove contaminated clothing; obtain medical advice if irritation develops.
      • Ingestion: rinse mouth; do not induce vomiting; seek medical attention as needed.
    • Fire safety: Organic solid; use water fog, CO2, dry chemical, or foam appropriate for surrounding materials. Combustion may produce NOx/COx.
    • Handling/storage: Keep container tightly closed, dry, and at room temperature (per Product Data). Avoid prolonged exposure to heat/humidity. Good housekeeping to prevent residue buildup.
Solvent Selection

This product is a solid, zwitterionic cyclic amino acid; solvent selection focuses on dissolution for reactions or biochemical use rather than extraction.

  • General solubility profile (literature/general):

    • Water: high solubility, increasing in acidic (pH <2.5) or basic (pH >10.5) media
    • Alcohols: limited solubility unless ion-paired or with co-solvents
    • Polar aprotic (DMSO, DMF): good solubility; useful for stock solutions
    • Nonpolar (Et2O, hexane, toluene): essentially insoluble
  • Practical choices:

    • For synthetic coupling: dissolve in water, MeOH/H2O, or DMF; adjust pH with base (e.g., NaHCO3) to generate the carboxylate for phase-transfer strategies, or keep slightly acidic to suppress amine reactivity until activation.
    • For peptide/amide couplings: anhydrous DMF, NMP, or DCM/DMF mixtures with coupling reagents (e.g., HATU/DIPEA) are standard.
    • For biochemical stocks: prepare 0.1–1.0 M in water or buffer; filter sterilize (0.22 µm) if sterility is needed.
  • Comparison (general):

    • L-Pipecolic acid vs L-proline: L-proline is more soluble in some organics and more commonly used as an organocatalyst; L-pipecolic acid offers a higher basicity (piperidine N) and different steric environment, which can be advantageous in select transformations.
Storage and Reconstitution
  • Item-specific storage/shipping (from Product Data):

    • Storage conditions: Room temperature
    • Shipped in: Normal conditions
  • General storage guidance (small-molecule amino acid; not a specification):

    • Keep container tightly closed in a dry place. Protect from excessive humidity to maintain accurate mass and prevent surface caking.
    • If long-term storage is anticipated, a desiccator or dry cabinet is recommended. Avoid strong light/heat.
  • Reconstitution and solution stability (general/literature):

    • Solvents: Water, dilute acid (e.g., 0.1 M HCl), dilute base (e.g., 0.1 M NaOH), or polar aprotic solvents (DMF/DMSO).
    • Concentrations: Commonly 0.1–1.0 M for stock solutions, depending on application and pH.
    • pH adjustment: For rapid dissolution, acidify slightly (pH 2–3) or basify (pH 10–11). Return to target pH after mixing with buffers/solutions.
    • Sterile use: Pass through 0.22 µm filter into sterile vials. Prepare fresh as needed to minimize bioburden.
    • Stability: Aqueous solutions are generally stable for days at 2–8 °C; for longer storage, aliquot and freeze at −20 °C to reduce microbial growth. Avoid repeated freeze–thaw of the same aliquot.
  • Labeling reminder: For research use only. Refer to the lot-specific CoA and SDS for definitive guidance on quality attributes and safe handling.

Structure and Identity

Brief overview: L-Pipecolic acid (also called (S)-piperidine-2-carboxylic acid) is a six-membered cyclic amino acid, the homolog of L-proline with an additional methylene in the ring. The chiral center is at C2 bearing the carboxyl group and the ring nitrogen.

  • Item-specific (from Product Data):

    • SKU: P106214
    • CAS: 3105-95-1
    • Storage: Room temperature; shipped under normal conditions
    • Research use: For research use only
    • Other identifiers (InChIKey, SMILES, MF, MW): Not specified for this item; refer to CoA/Spec Sheet.
  • Literature identity values (for reference; not item-specific specifications):

    • Synonyms: L-pipecolate; (S)-piperidine-2-carboxylic acid
    • Molecular formula: C6H11NO2 (literature)
    • Molecular weight: 129.16 g/mol (literature)
    • Stereochemistry: L- (S) configuration at the 2-position of the piperidine ring (Cα)
    • SMILES (one representation): O=C(O)[C@@H]1NCCCC1 (literature)
    • Core functional groups: secondary amine (within piperidine), carboxylic acid (α to N)
  • 2D structural description (general chemistry knowledge):

    • A saturated six-membered piperidine ring (chair conformation) containing one ring nitrogen. At the carbon adjacent to nitrogen (C2), a carboxylate-bearing stereocenter is present with L-configuration. In neutral drawings, the molecule exists as a zwitterion with –NH2+ and –COO− depending on pH. The ring resembles proline’s pyrrolidine but with one extra –CH2– unit, affecting basicity and conformational preferences.
Synthetic Utility
  • Functional group set:

    • Carboxylic acid (α to a chiral center) enables amide couplings, esterifications, decarboxylations, and activation to acyl derivatives.
    • Secondary amine embedded in a six-membered ring allows N-acylation, N-alkylation, protection (Boc/Cbz/Fmoc), and quaternization.
  • Retrosynthetic value (general/literature):

    • Serves as a chiral pool starting material for piperidine frameworks prevalent in alkaloids and drug-like scaffolds. Transformations that conserve stereochemistry at C2 enable rapid assembly of substituted pipecolates and bicyclic systems.
  • Named/representative reactions:

    • Amide bond formation with HATU/HBTU/EDC+DIC/HOBt or Oxyma to give pipecolamides.
    • Curtius/Schmidt-type rearrangements of activated carboxyl derivatives to access ureas/carbamates.
    • Formation of N-hydroxyphthalimide (NHPI) esters for decarboxylative cross-coupling (photoredox/Ni) to forge C(sp3)–C bonds from the α-position (literature trend for amino acid derivatives).
    • Esterification (Fischer/Steglich) to tunable pipecolate esters for subsequent manipulations (e.g., SN2′, hydrogenations).
  • Selectivity/control tips:

    • Protect the more nucleophilic ring nitrogen to avoid competitive N-acylation during activation of the acid.
    • Avoid high-temperature, strongly basic conditions that may epimerize the stereocenter; use mild bases (DIPEA, NMM) and low temperatures.
    • For N-alkylation, pre-form the hydrochloride and liberate base in situ, or use Mitsunobu-type approaches on suitable alcohol partners to control over-alkylation.
Target Specificity

Not applicable. This product is a small-molecule amino acid derivative, not an antibody, enzyme, or affinity reagent. No antigen/epitope or species reactivity is relevant. For biochemical pathway context, see the Biological Roles section.

Perguntas frequentes

What is the purity of this product?
This product is supplied at ≥98% purity (chemical assay). Lot-specific values are stated on the Certificate of Analysis.
How should this product be stored?
Store at room temperature.
How is this product shipped?
This product ships under standard ambient conditions. No temperature-controlled packaging is required.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 3105-95-1, the molecular formula is C6H11NO2, and the molecular weight is 129.16 g/mol. InChIKey HXEACLLIILLPRG-YFKPBYRVSA-N.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Deseja que lhe enviemos uma mensagem quando tivermos descontos disponíveis?

Lembrar-me mais tarde

Obrigado! Por favor, verifique a sua caixa de entrada de e-mail para confirmar.

Ops! As notificações estão desativadas.